Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-03-06

Clinical Trial Update: Tobradex BID Compared to TOBRADEX and TOBREX/Vehicle [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Tobradex BID with TOBRADEX and TOBREX/Vehicle for post-surgical inflammation was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TOBREX (TOBRAMYCIN)
  • Tobradex (tobramycin and dexamethasone)

Snippet

Sponsor: Alcon Research | Conditions: Post-surgical Inflammation | Phase 3 | Status: WITHDRAWN